Skip to main content

Table 1 Patient characteristics and PPI usage details

From: Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use

Characteristic (n)

Category

n (%)

Sex (154)

Male

150 (97.4)

Female

4 (2.6)

Race (154)

White

142 (92.2)

Black

6 (3.9)

Other

6 (3.9)

Duration of PPI use (156)

0–2 months

48 (30.8)

2 months to 2 years

34 (21.8)

3–5 years

20 (12.8)

> 5 years

54 (34.6)

Name of current PPI (156)

Omeprazole

92 (58.9)

Pantoprazole

58 (37.2)

Lansoprazole

4 (2.6)

Esomeprazole

2 (1.3)

Interval of PPI (156)

Once a day

103 (66)

Twice a day

52 (33.3)

As needed

1 (0.6)

Route of PPI (156)

Oral

154 (98.7)

Intravenous

2 (1.3)

Medical provider who initiated the PPI (156)

Primary care physician

91 (58.3)

Internal medicine

47 (30.1)

Surgery

11 (7.1)

Gastroenterology

7 (4.5)

Setting where the PPI was started (156)

Outpatient

98 (62.8)

Non-ICU

53 (34)

ICU

5 (3.2)

  1. Mean age (standard deviation) = 70.9 years (9.3). Median length of hospital stay (interquartile range) = 11 days (13). PPI proton pump inhibitor, ICU intensive care unit